Global Oncology Biosimilars Market Forecast to 2031: Growth Opportunities, and Future Outlook
The global Oncology Biosimilars Market is witnessing significant expansion, driven by the increasing burden of cancer and the need for cost-effective biologic therapies. The market is expected to reach US$ 26,618 million by 2031, registering a robust CAGR of 16.3% during 2025–2031. This strong growth reflects the rising adoption of biosimilars as viable alternatives to expensive biologic...
0 Comments 0 Shares 1K Views 0 Reviews